Your browser doesn't support javascript.
loading
Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin.
Patel, Sandip H; George, Tiffany L; Wang, Tzu-Fei; Vogt, Sherry M; Folefac, Edmund; Xu, Menglin; Yang, Yuanquan; Parikh, Anish B; Verschraegen, Claire F; Clinton, Steven K; Yin, Ming.
Afiliación
  • Patel SH; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • George TL; Division of Hematology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • Wang TF; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • Vogt SM; Division of Hematology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • Folefac E; Division of Hematology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • Xu M; Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada.
  • Yang Y; Department of Pharmacy, The Ohio State University James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio.
  • Parikh AB; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • Verschraegen CF; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • Clinton SK; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
  • Yin M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
Cancer ; 127(6): 938-945, 2021 03 15.
Article en En | MEDLINE | ID: mdl-33216354

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tromboembolia / Heparina de Bajo-Peso-Molecular / Receptores de Factores de Crecimiento Endotelial Vascular / Inhibidores de Proteínas Quinasas / Inhibidores del Factor Xa / Hemorragia / Neoplasias Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tromboembolia / Heparina de Bajo-Peso-Molecular / Receptores de Factores de Crecimiento Endotelial Vascular / Inhibidores de Proteínas Quinasas / Inhibidores del Factor Xa / Hemorragia / Neoplasias Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article